Literature DB >> 7541284

Vascular actions of thrombin receptor-derived polypeptides: structure-activity profiles for contractile and relaxant effects in rat aorta.

A A Laniyonu1, M D Hollenberg.   

Abstract

1. Using endothelium-denuded and intact rat aortic rings, we have determined the contractile and relaxant structure-activity profile for a series of thrombin receptor-derived polypeptides (TRPs) based on the human and rat receptor sequences: SFLLR (P5), SFLLR-NH2 (P5-NH2) SFFLR (Rat P5), SFFLR-NH2 (Rat P5-NH2), SFLLRNP (P7), SFLLRNP-NH2 (P7-NH2), SFFLRNP (Rat P7), SFFLRNP-NH2 (Rat P7-NH2), and SFLLRNPNDKYEPF (P14). 2. A contractile response to thrombin and the TRPs in the endothelium-denuded aortic tissue was minimal or absent in preparations obtained from animal weighing less than 180 g (< 6 weeks of age), but increased with animal size, plateauing in tissues derived from animals weighing between 320 and 420 g (about 9 to 14 weeks of age). In contrast, the contractile responses to KCl and noradrenaline did not differ in the tissues and relaxant responses to the TRPs in endothelium-intact aortic preparations were comparable for tissues obtained from either young (< or = 180 g) or older (> or = 320 g) animals. 3. The contractile response of the endothelium-denuded preparation to thrombin and the TRPs showed marked cross-desensitization: the relaxation response of the intact rings did not desensitize to the TRPs. 4. The relative potencies for the TRPs in the aortic contraction assay were comparable to those for the relaxation assay, but were distinct from the relative potencies we measured previously in a rat gastric longitudinal muscle contraction assay. Further, P5 behaved as a partial agonist in the aortic contraction assay, whereas it had been observed to be a full agonist in the gastric contraction assay. 5. The contractile activity of P5-NH2 in endothelium intact aortic rings was low or absent, but in the presence of the nitric oxide synthase inhibitor, N omega-nitro-L-arginine-methyl ester (L-NAME), the contractions in the intact preparation were equivalent to the response of the endothelium-denuded preparation in the absence of L-NAME.6. The contractile response of the endothelium-denuded aortic preparation to P5-NH2 was inhibited by nifedipine and the kinase C antagonist, chelerythrine, but was resistant to the action of indomethacin,tetrodotoxin and the tyrosine kinase inhibitor, genistein.7 We conclude that the receptor system for the TRPs in the aortic smooth muscle elements, responsible for the contractile response, is similar to the aortic endothelial cell receptor responsible for the relaxation response, but is distinct from the receptor that we have previously characterized in gastric longitudinal smooth muscle, results pointing to the presence of receptor subtypes in the vascular and gastric smooth muscle elements.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541284      PMCID: PMC1510399          DOI: 10.1111/j.1476-5381.1995.tb14957.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

Authors:  T K Vu; D T Hung; V I Wheaton; S R Coughlin
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

2.  cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization.

Authors:  U B Rasmussen; V Vouret-Craviari; S Jallat; Y Schlesinger; G Pagès; A Pavirani; J P Lecocq; J Pouysségur; E Van Obberghen-Schilling
Journal:  FEBS Lett       Date:  1991-08-19       Impact factor: 4.124

3.  Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists.

Authors:  T P Kenakin; P H Morgan
Journal:  Mol Pharmacol       Date:  1989-02       Impact factor: 4.436

Review 4.  Responses of aortic smooth muscle to thrombin and thrombin analogues.

Authors:  D A Walz; G F Anderson; J W Fenton
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

5.  Comparison of responses elicited by alpha-thrombin in isolated canine basilar, coronary, mesenteric, and renal arteries.

Authors:  R P White; Y Shirasawa; J T Robertson
Journal:  Blood Vessels       Date:  1984

6.  Characterization of the thrombin-induced contraction of vascular smooth muscle.

Authors:  V M Haver; D H Namm
Journal:  Blood Vessels       Date:  1984

7.  Thrombin-elicited contractile responses of aortic smooth muscle.

Authors:  D A Walz; G F Anderson; R E Ciaglowski; M Aiken; J W Fenton
Journal:  Proc Soc Exp Biol Med       Date:  1985-12

8.  Mechanisms of adenosine triphosphate-, thrombin-, and trypsin-induced relaxation of rat thoracic aorta.

Authors:  R M Rapoport; M B Draznin; F Murad
Journal:  Circ Res       Date:  1984-10       Impact factor: 17.367

9.  Aminopeptidase modulation of the pharmacological responses to synthetic thrombin receptor agonists.

Authors:  D Godin; F Marceau; C Beaulé; F Rioux; G Drapeau
Journal:  Eur J Pharmacol       Date:  1994-03-03       Impact factor: 4.432

10.  Cerebral arterial contractions induced by human and bovine thrombin.

Authors:  R P White; C E Chapleau; M Dugdale; J T Robertson
Journal:  Stroke       Date:  1980 Jul-Aug       Impact factor: 7.914

View more
  11 in total

1.  Differential DNA synthesis in response to activation of protease-activated receptors on cultured guinea-pig tracheal smooth muscle cells.

Authors:  Randolph Corteling; Olivier Bonneau; Stephane Ferretti; Mireille Ferretti; Alexandre Trifilieff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-06-18       Impact factor: 3.000

Review 2.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

3.  Modulation by protease-activated receptors of the rat duodenal motility in vitro: possible mechanisms underlying the evoked contraction and relaxation.

Authors:  A Kawabata; R Kuroda; H Nishikawa; K Kawai
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

4.  Proteinase-activated receptors 1 and 2 and the regulation of porcine coronary artery contractility: a role for distinct tyrosine kinase pathways.

Authors:  Mahmoud El-Daly; Mahmoud Saifeddine; Koichiro Mihara; Rithwik Ramachandran; Christopher R Triggle; Morley D Hollenberg
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

5.  Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue.

Authors:  M Saifeddine; B al-Ani; C H Cheng; L Wang; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

6.  Dual modulation by thrombin of the motility of rat oesophageal muscularis mucosae via two distinct protease-activated receptors (PARs): a novel role for PAR-4 as opposed to PAR-1.

Authors:  A Kawabata; R Kuroda; N Kuroki; H Nishikawa; K Kawai
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

7.  Enhancement of vascular permeability by specific activation of protease-activated receptor-1 in rat hindpaw: a protective role of endogenous and exogenous nitric oxide.

Authors:  A Kawabata; R Kuroda; H Nishikawa; T Asai; K Kataoka; M Taneda
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

8.  Protease activated receptors in cardiovascular function and disease.

Authors:  Junor A Barnes; Shamjeet Singh; Aldrin V Gomes
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

9.  Proteinase-activated receptor-1 (PAR-1) activation contracts the isolated human renal artery in vitro.

Authors:  Michele Tognetto; Michael R D'Andrea; Marcello Trevisani; Remo Guerrini; Severo Salvadori; Lorella Spisani; Carlo Daniele; Patricia Andrade-Gordon; Pierangelo Geppetti; Selena Harrison
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

10.  Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport.

Authors:  N Vergnolle; W K Macnaughton; B Al-Ani; M Saifeddine; J L Wallace; M D Hollenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.